Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Tcmages Pharmaceutical, widely known as Beijing Kangrentang, is a leading Chinese pharmaceutical company specializing in the modernization of Traditional Chinese Medicine (TCM). Founded in 2003, the company is a pioneer in the research, development, and industrial production of concentrated TCM granules, which serve as a standardized alternative to traditional herbal decoctions. As a core subsidiary of China Traditional Chinese Medicine Holdings, it operates advanced manufacturing facilities that adhere to strict GMP standards and utilizes proprietary extraction technologies. Their product portfolio includes over 600 varieties of single-herb granules and compound formulas used extensively in hospitals across China. The company is recognized for its significant role in establishing national standards for TCM granule quality and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Kangrentang Pharmaceutical Group.